Combination Therapy Of Polymyxin B And Amikacin For Community-Acquired Pseudomonas Aeruginosa Pneumonia With Mods In A Previously Healthy Patient: A Case Report

Junyu Wang, Lu Yun, Hong Zhao,Xiangpeng Li

INFECTION AND DRUG RESISTANCE(2021)

Cited 2|Views0
No score
Abstract
Background: Pseudomonas aeruginosa (P. aeruginosa) is an uncommon but fatal causative pathogen for community-acquired pneumonia (CAP). Few case reports described the previously healthy individuals with CAP caused by P. aeruginosa.Case Presentation: A 67-year-old male farmer was referred to our hospital with a 6-day history of fever and shortness of breath. The radiologic findings revealed a dense consolidation site in the right lung, considering infection lesion, accompanying with mediastinal and right hilar lymphadenopathy. Sputum sample results showed P. aeruginosa and multidrug-resistant Acinetobacter baumannii. The combination of polymyxin B and amikacin was given to him based on the lab results, the manifestations of the patient were alleviated and he returned to his home after a 35-day hospitalization.Conclusion: We need to keep close attention to community-acquired P. aeruginosa pneumonia due to its high mortality, further studies are needed to identify the infectious source, effective examination, and optimal therapy including medications and duration.
More
Translated text
Key words
Pseudomonas aeruginosa, community-acquired pneumonia, polymyxin B and amikacin, a case report
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined